Apoptosis of oligodendrocytes via fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis

被引:131
作者
Hövelmeyer, N
Hao, ZY
Kranidioti, K
Kassiotis, G
Buch, T
Frommer, F
von Hoch, L
Kramer, D
Minichiello, L
Kollias, G
Lassmann, H
Waisman, A
机构
[1] Univ Mainz, Dept Med 1, D-55131 Mainz, Germany
[2] Univ Cologne, Lab Mol Immunol, Inst Genet, Cologne, Germany
[3] Biomed Sci Res Ctr Al Fleming, Inst Immunol, Vari, Greece
[4] European Mol Biol Lab, Mouse Biol Unit, Rome, Italy
[5] Univ Vienna, Inst Brain Res, Vienna, Austria
关键词
D O I
10.4049/jimmunol.175.9.5875
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, immunization with myelin Ags leads to demyelination and paralysis. To investigate which molecules are crucial for the pathogenesis of EAE, we specifically assessed the roles of the death receptors Fas and TNF-R1. Mice lacking Fas expression in oligodendrocytes (ODCs) were generated and crossed to TNF-R1-deficient mice. To achieve specific deletion of a loxP-flanked fas allele in ODCs, we generated a new insertion transgene, expressing the Cre recombinase specifically in ODCs. Fas inactivation alone as well as the complete absence of TNF-R1 protected mice partially from EAE induced by the immunization with myelin ODC glycoprotein. The double-deficient mice, however, showed almost no clinical signs of EAE after immunization. Histological analysis revealed that demyelination was suppressed in CNS tissue and that lymphocyte infiltration was notably reduced. We conclude that the death receptors Fas and TNF-R1 are major initiators of ODC apoptosis in EAE. Although only moderate reduction of lymphocyte infiltration into CNS tissue was observed, the absence of these receptors appears to confer protection from demyelination and development of clinical disease.
引用
收藏
页码:5875 / 5884
页数:10
相关论文
共 55 条
[1]   Enhanced and accelerated lymphoproliferation in Fas-null mice [J].
Adachi, M ;
Suematsu, S ;
Suda, T ;
Watanabe, D ;
Fukuyama, H ;
Ogasawara, J ;
Tanaka, T ;
Yoshida, N ;
Nagata, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :2131-2136
[2]  
Bonetti B, 1997, J IMMUNOL, V159, P5733
[3]   Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis [J].
Bonetti, B ;
Raine, CS .
ANNALS OF NEUROLOGY, 1997, 42 (01) :74-84
[4]  
Bruno R, 2002, EUR J IMMUNOL, V32, P2737, DOI 10.1002/1521-4141(2002010)32:10<2737::AID-IMMU2737>3.0.CO
[5]  
2-0
[6]   ALTERING THE GENOME BY HOMOLOGOUS RECOMBINATION [J].
CAPECCHI, MR .
SCIENCE, 1989, 244 (4910) :1288-1292
[7]   Nuclear expression of S10013 in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation [J].
Deloulme, JC ;
Raponi, E ;
Gentil, BJ ;
Bertacchi, N ;
Marks, A ;
Labourdette, G ;
Baudier, J .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 27 (04) :453-465
[8]  
Dittel BN, 1999, J IMMUNOL, V162, P6392
[9]  
Dittel Bonnie N., 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P381
[10]   Cell death and birth in multiple sclerosis brain [J].
Dowling, P ;
Husar, W ;
Menonna, J ;
Donnenfeld, H ;
Cook, S ;
Sidhu, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 149 (01) :1-11